中华病理学杂志
中華病理學雜誌
중화병이학잡지
Chinese Journal of Pathology
2014年
6期
364-369
,共6页
刘绮颖%陈庆明%喻林%王坚
劉綺穎%陳慶明%喻林%王堅
류기영%진경명%유림%왕견
软组织肿瘤%间皮瘤%免疫组织化学
軟組織腫瘤%間皮瘤%免疫組織化學
연조직종류%간피류%면역조직화학
Soft tissue neoplasms%Mesothelioma%Immunohistochemistry
目的 分析肉瘤样恶性间皮瘤(sarcomatoid malignant mesothelioma,SMM)的临床病理学特征,探讨SMM的诊断要点及其鉴别诊断.方法 回顾性复习2009年1月至2013年9月收集的22例SMM的临床资料、病理学形态和免疫表型,分析预后资料.结果 22例患者的平均年龄54岁(范围24~ 73岁),男女比例为1.0∶1.2.多数患者无明确的石棉接触史.14例发生于胸膜,8例位于腹膜.临床上,发生于胸膜者多因咳嗽、气喘和胸痛就诊,发生于腹膜者多有恶心、腹胀和腹痛等症状.影像学显示,多数病例(8/11)表现为胸壁或腹腔内大小不等的结节状肿块,仅少数病例(3/11)表现为胸膜弥漫性增厚.所有病例均无肺或腹腔实质脏器内占位性病变.组织学上,19例呈纤维肉瘤样或未分化多形性肉瘤样,2例为促结缔组织增生性,1例伴有骨肉瘤样分化.免疫组织化学检测显示,所有病例均表达广谱细胞角蛋白(AE1/AE3),多数病例尚表达D2-40 (15/20),部分病例弱阳性或灶性表达钙视网膜蛋白(9/21)和WT1(10/14),不表达甲状腺转录因子-1、Napsin A、肺表面活性物质相关蛋白A、p63和CD34等.随访11例(1~36个月),6例带瘤生存,1例复发,4例死亡.中位生存时间5个月(平均8个月).结论 SMM的诊断必需结合临床、影像学和病理学资料.广谱细胞角蛋白联合D2-40标记对SMM的诊断具有提示作用,而钙视网膜蛋白仅在部分SMM病例中有弱阳性表达,WT1常为灶性表达.诊断SMM之前还需注意除外肉瘤样癌、滑膜肉瘤、孤立性纤维性肿瘤和纤维性胸膜炎等具有相似形态的梭形细胞肿瘤.
目的 分析肉瘤樣噁性間皮瘤(sarcomatoid malignant mesothelioma,SMM)的臨床病理學特徵,探討SMM的診斷要點及其鑒彆診斷.方法 迴顧性複習2009年1月至2013年9月收集的22例SMM的臨床資料、病理學形態和免疫錶型,分析預後資料.結果 22例患者的平均年齡54歲(範圍24~ 73歲),男女比例為1.0∶1.2.多數患者無明確的石棉接觸史.14例髮生于胸膜,8例位于腹膜.臨床上,髮生于胸膜者多因咳嗽、氣喘和胸痛就診,髮生于腹膜者多有噁心、腹脹和腹痛等癥狀.影像學顯示,多數病例(8/11)錶現為胸壁或腹腔內大小不等的結節狀腫塊,僅少數病例(3/11)錶現為胸膜瀰漫性增厚.所有病例均無肺或腹腔實質髒器內佔位性病變.組織學上,19例呈纖維肉瘤樣或未分化多形性肉瘤樣,2例為促結締組織增生性,1例伴有骨肉瘤樣分化.免疫組織化學檢測顯示,所有病例均錶達廣譜細胞角蛋白(AE1/AE3),多數病例尚錶達D2-40 (15/20),部分病例弱暘性或竈性錶達鈣視網膜蛋白(9/21)和WT1(10/14),不錶達甲狀腺轉錄因子-1、Napsin A、肺錶麵活性物質相關蛋白A、p63和CD34等.隨訪11例(1~36箇月),6例帶瘤生存,1例複髮,4例死亡.中位生存時間5箇月(平均8箇月).結論 SMM的診斷必需結閤臨床、影像學和病理學資料.廣譜細胞角蛋白聯閤D2-40標記對SMM的診斷具有提示作用,而鈣視網膜蛋白僅在部分SMM病例中有弱暘性錶達,WT1常為竈性錶達.診斷SMM之前還需註意除外肉瘤樣癌、滑膜肉瘤、孤立性纖維性腫瘤和纖維性胸膜炎等具有相似形態的梭形細胞腫瘤.
목적 분석육류양악성간피류(sarcomatoid malignant mesothelioma,SMM)적림상병이학특정,탐토SMM적진단요점급기감별진단.방법 회고성복습2009년1월지2013년9월수집적22례SMM적림상자료、병이학형태화면역표형,분석예후자료.결과 22례환자적평균년령54세(범위24~ 73세),남녀비례위1.0∶1.2.다수환자무명학적석면접촉사.14례발생우흉막,8례위우복막.림상상,발생우흉막자다인해수、기천화흉통취진,발생우복막자다유악심、복창화복통등증상.영상학현시,다수병례(8/11)표현위흉벽혹복강내대소불등적결절상종괴,부소수병례(3/11)표현위흉막미만성증후.소유병례균무폐혹복강실질장기내점위성병변.조직학상,19례정섬유육류양혹미분화다형성육류양,2례위촉결체조직증생성,1례반유골육류양분화.면역조직화학검측현시,소유병례균표체엄보세포각단백(AE1/AE3),다수병례상표체D2-40 (15/20),부분병례약양성혹조성표체개시망막단백(9/21)화WT1(10/14),불표체갑상선전록인자-1、Napsin A、폐표면활성물질상관단백A、p63화CD34등.수방11례(1~36개월),6례대류생존,1례복발,4례사망.중위생존시간5개월(평균8개월).결론 SMM적진단필수결합림상、영상학화병이학자료.엄보세포각단백연합D2-40표기대SMM적진단구유제시작용,이개시망막단백부재부분SMM병례중유약양성표체,WT1상위조성표체.진단SMM지전환수주의제외육류양암、활막육류、고립성섬유성종류화섬유성흉막염등구유상사형태적사형세포종류.
Objective To elaborate on the clinical and pathologic features of sarcomatoid malignant mesothelioma (SMM),its diagnostic criteria and differential diagnoses.Methods Twenty-two cases of SMM retrieved from in-house and consultation files (between January 2009 to September 2013) were reviewed with emphasis on the clinicopathologic characteristics,immunophenolypes and the prognostic impact.Results The mean age of the patients was 54 years (ranged from 24-73 years).There was no sexual predilection and the majorily of the patients did not have history-of asbestos exposure.Overall,14 tumors developed in the pleura and 8 cases arose from the peritoneal cavity-.Clinically,patients presented signs and symptoms in accord with the location of the tumors,notably coughing,shortness of breath,and chest pain for patients with pleural origin,and nausea,abdominal distention and abdominal pain for those with peritoneal primary-.In most cases,CT and MRI scan demonstrated lobulated masses (8/11).However,diffuse infiltrative growth patterns were observed exclusively in a minority of pleural cases (3/11).No visceral lesion was observed in any-case.Histologically,19 cases had either fibrosarcomatous or undifferentiated pleomorphic sarcoma-like appearance.Two cases were consistent with desmoplastic mesothelioma.One case contained osteosarcomatous element.All cases expressed pan-cytokeratin (AE1/AE3),and most cases were also positive for D2-40 (15/20).The staining of calretinin (9/21) and WT1 (10/14) was generally weak and focal.They were all negative for TTF-1,napsin A,SP-A,p63 and CD34.Follow-up information (range from 1 to 36 months) was available in 11 cases,6 of which were alive with unresectable tumor,1 patient with recurrent disease and 4 patients succumbed to disease.The overall survival was 5 months (mean 8 months).Conclusions The diagnosis of SMM is achieved by comprehensive evaluation of medical history,imageological and pathological findings.Since calretinin immunoreactivity is infrequently observed in SMM,application of pan-cytokeratin and D2-40 immunostains offers a reasonable alternative for diagnosis.Diagnosis of SMM can be made by excluding a variety of spindle cell neoplasms with overlapping features,such as sarcomatoid carcinoma,synovial sarcoma,solitary fibrous tumor and fibrous pleuritis.